Follow the 株式会社リボミック share price and the full management transaction log of the company, a publicly traded company based in Japan. Shares are listed on the JP market, under the supervision of EDINET (Japan FSA). Market capitalisation: €4.8bn. The latest transaction was reported on 22 June 2026 (Holding update). Among the most active insiders: Evo Fund. The full history is accessible without an account.
25
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
n/a
n/a
Sell Volume
18Σ signal
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Ribomic Inc. es una empresa japonesa que cotiza en el mercado XTKS, especializada en el desarrollo de fármacos basados en la tecnología de ribozimas. Se centra en tratamientos innovadores para diversas enfermedades.